LONDON & BREMERHAVEN, Germany--(BUSINESS WIRE)--Praesidian Capital Europe, a leading provider of senior and subordinated debt and growth capital in the United Kingdom and Europe, announced today its €8.5 million investment of first lien debt in Medical Laboratory Bremerhaven (the “Company”). The funds will be used to recapitalize the business while providing growth capital to allow Medical Laboratory Bremerhaven to accelerate acquisitions of smaller laboratories in its market area. Based in Bre